+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iodine Radioisotope Market - Global Forecast 2026-2032- Product Image
Iodine Radioisotope Market - Global Forecast 2026-2032- Product Image
Sale

Iodine Radioisotope Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150892
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iodine Radioisotope Market is projected to reach USD 374.97 Million in 2026. It is expected to continue growing at a CAGR of 8.06%, reaching USD 594.19 Million by 2032.

Iodine Radioisotopes: Executive Overview

Iodine radioisotopes are radioactive forms of iodine used across nuclear medicine, diagnostic imaging, therapy, biomedical research, and selected industrial applications. Their value depends on reliable isotope production, specialized handling, regulatory compliance, radiopharmacy capacity, and clinical expertise. The field is shaped by the balance between medical need, reactor and accelerator infrastructure, patient-safety requirements, and the availability of trained personnel.

How Production, Care Pathways, and Regulation Are Changing

The iodine radioisotope landscape is being reshaped by wider adoption of personalized nuclear medicine, more selective therapeutic approaches, and efforts to improve supply resilience. Healthcare systems are strengthening coordination between isotope producers, hospitals, radiopharmacies, logistics providers, and regulators. At the same time, stricter requirements for transport, radiation protection, quality assurance, waste management, and traceability are increasing the importance of integrated operating models. Production diversification and improved scheduling are also helping stakeholders manage the short half-lives and time-sensitive distribution requirements associated with several iodine radioisotopes.

Artificial Intelligence Improves Planning, Precision, and Safety

Artificial intelligence is contributing to iodine radioisotope workflows through image interpretation, treatment planning, patient selection, dosimetry support, inventory management, and logistics optimization. Machine-learning tools can help clinicians identify patterns across imaging and laboratory data, while predictive systems may improve scheduling of isotope delivery and treatment capacity. Adoption remains dependent on high-quality data, clinical validation, cybersecurity, explainability, and compliance with medical-device and privacy requirements. AI is therefore best viewed as an augmentation layer that supports qualified professionals rather than replacing clinical judgment or radiation-safety controls.

Regional Dynamics Across the Global Iodine Radioisotope Ecosystem

North America combines advanced nuclear medicine infrastructure with strong clinical research, regulatory oversight, and specialized radiopharmacy networks. Europe benefits from extensive cross-border scientific collaboration, established hospital systems, and coordinated attention to supply continuity, while differences in reimbursement and national regulation can affect access. Asia-Pacific is supported by expanding diagnostic and oncology capacity, growing research activity, and increasing investment in isotope production and nuclear medicine services. Latin America is advancing through selected tertiary-care centers and public-health initiatives, although infrastructure, workforce, and distribution constraints remain uneven. The Middle East is developing specialized medical centers and isotope capabilities, particularly where national healthcare investment supports nuclear medicine. Africa shows important potential but continues to face limitations involving equipment, trained personnel, financing, and dependable access to radiopharmaceutical services.

Strategic Perspectives from ASEAN, BRICS, the EU, G7, GCC, and NATO

ASEAN members are working within varied healthcare and regulatory environments, making regional training, shared infrastructure, and coordinated procurement particularly relevant. BRICS economies span major production, research, and clinical capabilities alongside significant differences in access and standards, creating opportunities for technical cooperation and capacity building. The European Union emphasizes harmonized safety principles, cross-border coordination, and resilient medical-isotope supply chains. G7 countries generally contribute advanced research, clinical expertise, and regulatory practices, while also addressing workforce and infrastructure pressures. GCC states are strengthening specialized healthcare capacity through investment in hospitals, radiopharmacies, and research. NATO members, considered as a broad group, bring diverse civilian nuclear-medicine systems and may benefit from coordinated resilience planning for critical healthcare supplies and transport.

Country-Level Priorities from Australia to the United States

Australia combines medical research strengths with a geographically dispersed healthcare system, making logistics and workforce distribution important considerations. Brazil and Mexico are expanding access through major urban and tertiary-care institutions while continuing to address regional disparities. Canada and the United States have sophisticated nuclear-medicine capabilities, with priorities including supply continuity, clinical capacity, and responsible innovation. China and India are developing broad diagnostic and therapeutic networks alongside domestic research and production capabilities. Japan and South Korea maintain advanced technology ecosystems and strong clinical expertise, while France, Germany, Italy, Spain, and the United Kingdom benefit from established European nuclear-medicine infrastructure and research institutions. Russia retains scientific and nuclear-sector capabilities, although access to equipment, collaboration, and international logistics can be affected by regulatory and geopolitical conditions.

Actions for Leaders: Build Resilience, Evidence, and Clinical Capacity

Industry leaders should diversify qualified isotope sources, establish contingency plans for transport interruptions, and strengthen end-to-end chain-of-custody monitoring. Partnerships with hospitals and radiopharmacies should focus on demand coordination, timely delivery, validated handling, and patient-centered treatment pathways. Organizations should invest in radiation-safety training, dosimetry expertise, quality systems, and workforce development, particularly in underserved regions. AI initiatives should begin with clearly defined clinical or operational use cases, rigorous validation, human oversight, cybersecurity, and auditable governance. Leaders should also engage regulators and payers early, document clinical outcomes, and align expansion decisions with sustainable waste management and responsible use of nuclear materials.

Methodology for a Data-Grounded Executive Assessment

This executive summary uses the supplied market definition-iodine radioisotopes-and evaluates the field through established application, infrastructure, policy, technology, and geographic lenses. The assessment distinguishes verified structural developments from unsupported quantitative claims and does not infer market size, shares, or forecasts. Regional, group, and country perspectives are synthesized from observable differences in healthcare capacity, nuclear-medicine infrastructure, production capability, regulation, research activity, logistics, and workforce conditions. Artificial intelligence is assessed by its documented functional roles and by the governance requirements that influence safe adoption.

Conclusion: Resilience and Clinical Integration Define Progress

The iodine radioisotope field is advancing through closer integration of isotope production, radiopharmacy, imaging, therapy, research, and specialist care. Regional conditions differ substantially, but common priorities include dependable supply, rigorous safety, qualified personnel, validated clinical pathways, and responsible technology adoption. Organizations that combine operational resilience with evidence-based innovation and constructive regulatory engagement will be better positioned to improve access and outcomes while maintaining the high standards required for radioactive materials and patient care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iodine Radioisotope Market, by Product Type
7.1. Introduction
7.2. I 123
7.3. I 125
7.4. I 129
7.5. I 131
8. Iodine Radioisotope Market, by Application
8.1. Introduction
8.2. Diagnostic
8.2.1. Biomarker Analysis
8.2.2. Cancer Diagnostic Imaging
8.2.3. Thyroid Function Testing
8.3. Research
8.3.1. Pharmacokinetic Studies
8.3.2. Radiolabeling Studies
8.4. Therapeutic
8.4.1. Hyperthyroidism Treatment
8.4.2. Palliative Care
8.4.3. Thyroid Cancer Treatment
9. Iodine Radioisotope Market, by End User
9.1. Introduction
9.2. Diagnostic Centers
9.2.1. Hospital Affiliated Centers
9.2.2. Outpatient Centers
9.3. Hospitals
9.3.1. Private Hospitals
9.3.2. Public Hospitals
9.4. Pharmaceutical Companies
9.4.1. Biotech Firms
9.4.2. Large Pharma
9.5. Research Institutes
9.5.1. Academic Institutes
9.5.2. Government Labs
10. Iodine Radioisotope Market, by Grade
10.1. Introduction
10.2. Analytical Grade
10.3. Industrial Grade
10.4. Pharmaceutical Grade
11. Iodine Radioisotope Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Iodine Radioisotope Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Iodine Radioisotope Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. ANSTO Health
15.2. Bayer AG
15.3. Bracco Imaging S.p.A.
15.4. Cardinal Health, Inc.
15.5. Curium Pharma
15.6. Dongcheng Industrial Group
15.7. GE Healthcare
15.8. IBA Molecular
15.9. Institute for Radioelements
15.10. JSC Isotope
15.11. Jubilant Pharma Limited
15.12. Lantheus Holdings, Inc.
15.13. Mallinckrodt plc
15.14. Navidea Biopharmaceuticals, Inc.
15.15. NCM LLC
15.16. Nordion Inc.
15.17. Norgine BV
15.18. Samyoung Unitech Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iodine Radioisotope Market, Years Considered for the Study
FIGURE 2. Global Iodine Radioisotope Market, Research Design
FIGURE 3. Global Iodine Radioisotope Market, Research Framework
FIGURE 4. Global Iodine Radioisotope Market, Data Triangulation
FIGURE 5. Global Iodine Radioisotope Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iodine Radioisotope Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Iodine Radioisotope Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iodine Radioisotope Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Iodine Radioisotope Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iodine Radioisotope Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Iodine Radioisotope Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iodine Radioisotope Market Size, by Grade, 2025 vs 2032 (%)
FIGURE 13. Global Iodine Radioisotope Market Size, by Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iodine Radioisotope Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Iodine Radioisotope Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iodine Radioisotope Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Iodine Radioisotope Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Iodine Radioisotope Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Iodine Radioisotope Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iodine Radioisotope Market Segmentation & Coverage
TABLE 2. Global Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global I 123 Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global I 123 Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global I 123 Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global I 125 Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global I 125 Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global I 125 Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global I 129 Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global I 129 Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global I 129 Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global I 131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global I 131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global I 131 Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 17. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Biomarker Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Biomarker Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Biomarker Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Cancer Diagnostic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Cancer Diagnostic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Cancer Diagnostic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Thyroid Function Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Thyroid Function Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Thyroid Function Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Pharmacokinetic Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Pharmacokinetic Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Pharmacokinetic Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Radiolabeling Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Radiolabeling Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Radiolabeling Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Hyperthyroidism Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Hyperthyroidism Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Hyperthyroidism Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Palliative Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Palliative Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Palliative Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Thyroid Cancer Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Thyroid Cancer Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Thyroid Cancer Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hospital Affiliated Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hospital Affiliated Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hospital Affiliated Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Outpatient Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Outpatient Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Outpatient Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Biotech Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Biotech Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Biotech Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Government Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Government Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Government Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 88. Global Analytical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Analytical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Analytical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Industrial Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Industrial Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Industrial Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Pharmaceutical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Pharmaceutical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Pharmaceutical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 110. North America Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. North America Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. North America Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. North America Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 114. North America Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 115. North America Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 116. North America Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. North America Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 118. North America Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 119. North America Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 120. North America Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 121. North America Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 122. Latin America Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Latin America Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. Latin America Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Latin America Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 126. Latin America Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 127. Latin America Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 128. Latin America Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Latin America Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 130. Latin America Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 131. Latin America Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 132. Latin America Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 133. Latin America Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 134. Europe Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Europe Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Europe Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Europe Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 138. Europe Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 139. Europe Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 140. Europe Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Europe Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 142. Europe Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 143. Europe Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 144. Europe Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 145. Europe Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 146. Middle East Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Middle East Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Middle East Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Middle East Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 150. Middle East Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 151. Middle East Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 152. Middle East Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Middle East Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 154. Middle East Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 155. Middle East Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 156. Middle East Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 157. Middle East Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 158. Africa Iodine Radioisotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Africa Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. Africa Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Africa Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 162. Africa Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 163. Africa Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 164. Africa Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Africa Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 166. Africa Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 167. Africa Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 168. Africa Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 169. Africa Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 170. Global Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. ASEAN Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. ASEAN Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. ASEAN Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. ASEAN Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 175. ASEAN Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 176. ASEAN Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 177. ASEAN Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. ASEAN Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 179. ASEAN Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. ASEAN Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 181. ASEAN Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 182. ASEAN Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 183. GCC Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. GCC Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. GCC Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. GCC Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 187. GCC Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 188. GCC Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 189. GCC Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. GCC Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 191. GCC Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 192. GCC Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 193. GCC Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 194. GCC Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 195. European Union Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. European Union Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. European Union Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. European Union Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 199. European Union Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 200. European Union Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 201. European Union Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. European Union Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 203. European Union Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 204. European Union Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 205. European Union Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 206. European Union Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 207. BRICS Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. BRICS Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. BRICS Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. BRICS Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 211. BRICS Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 212. BRICS Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 213. BRICS Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. BRICS Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 215. BRICS Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 216. BRICS Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 217. BRICS Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 218. BRICS Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 219. G7 Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. G7 Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. G7 Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. G7 Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 223. G7 Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 224. G7 Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 225. G7 Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. G7 Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 227. G7 Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 228. G7 Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 229. G7 Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 230. G7 Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 231. NATO Iodine Radioisotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. NATO Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. NATO Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. NATO Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 235. NATO Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 236. NATO Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 237. NATO Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. NATO Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 239. NATO Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 240. NATO Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 241. NATO Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 242. NATO Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 243. Global Iodine Radioisotope Market Size, by Country, 2017-2032 (USD Million)
TABLE 244. United States Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 245. United States Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. United States Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. United States Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 248. United States Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 249. United States Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 250. United States Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. United States Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 252. United States Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 253. United States Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 254. United States Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 255. United States Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 256. Canada Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 257. Canada Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Canada Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Canada Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 260. Canada Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 261. Canada Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 262. Canada Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Canada Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 264. Canada Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 265. Canada Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 266. Canada Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 267. Canada Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 268. Mexico Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 269. Mexico Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Mexico Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Mexico Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 272. Mexico Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 273. Mexico Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 274. Mexico Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Mexico Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 276. Mexico Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 277. Mexico Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 278. Mexico Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 279. Mexico Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 280. Brazil Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 281. Brazil Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. Brazil Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Brazil Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 284. Brazil Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 285. Brazil Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 286. Brazil Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Brazil Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 288. Brazil Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 289. Brazil Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 290. Brazil Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 291. Brazil Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 292. United Kingdom Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 293. United Kingdom Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 294. United Kingdom Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. United Kingdom Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 296. United Kingdom Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 297. United Kingdom Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 298. United Kingdom Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. United Kingdom Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 300. United Kingdom Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 301. United Kingdom Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 302. United Kingdom Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 303. United Kingdom Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 304. Germany Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 305. Germany Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. Germany Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Germany Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 308. Germany Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 309. Germany Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 310. Germany Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Germany Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 312. Germany Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 313. Germany Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 314. Germany Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 315. Germany Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 316. France Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 317. France Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 318. France Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. France Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 320. France Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 321. France Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 322. France Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. France Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 324. France Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 325. France Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 326. France Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 327. France Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 328. Russia Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 329. Russia Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 330. Russia Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. Russia Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 332. Russia Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 333. Russia Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 334. Russia Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 335. Russia Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 336. Russia Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 337. Russia Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 338. Russia Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 339. Russia Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 340. Italy Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 341. Italy Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 342. Italy Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. Italy Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 344. Italy Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 345. Italy Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 346. Italy Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 347. Italy Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 348. Italy Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 349. Italy Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 350. Italy Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 351. Italy Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 352. Spain Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 353. Spain Iodine Radioisotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 354. Spain Iodine Radioisotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 355. Spain Iodine Radioisotope Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 356. Spain Iodine Radioisotope Market Size, by Research, 2017-2032 (USD Million)
TABLE 357. Spain Iodine Radioisotope Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 358. Spain Iodine Radioisotope Market Size, by End User, 2017-2032 (USD Million)
TABLE 359. Spain Iodine Radioisotope Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 360. Spain Iodine Radioisotope Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 361. Spain Iodine Radioisotope Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 362. Spain Iodine Radioisotope Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 363. Spain Iodine Radioisotope Market Size, by Grade, 2017-2032 (USD Million)
TABLE 364. China Iodine Radioisotope Market Size, 2017-2032 (USD Million)
TABLE 365. China Iodine

Companies Mentioned

  • ANSTO Health
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Dongcheng Industrial Group
  • GE Healthcare
  • IBA Molecular
  • Institute for Radioelements
  • JSC Isotope
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Mallinckrodt plc
  • Navidea Biopharmaceuticals, Inc.
  • NCM LLC
  • Nordion Inc.
  • Norgine BV
  • Samyoung Unitech Co., Ltd.

Related Topics

Related Reports

Iodine-131 Isotope Market - Global Forecast 2026-2032 - Product Image

Iodine-131 Isotope Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032 - Product Image

Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Iodine Market Report by Source, Form, Application, and Region 2026-2034 - Product Image

Iodine Market Report by Source, Form, Application, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Iodine - Global Strategic Business Report - Product Image

Iodine - Global Strategic Business Report

  • Report
  • 363 Pages
  • Global
From
Iodine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Iodine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.